66th ASH Annual Meeting: Getting Started and Transitioning to Outpatient Care for Patients With Relapsed or Refractory Multiple Myeloma

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member

denotes an abstract that is clinically relevant.

denotes that this is a recommended PHD Trainee Session.

denotes that this is a ticketed session.

Getting Started and Transitioning to Outpatient Care for Patients With Relapsed or Refractory Multiple Myeloma

Sponsor: Pfizer Oncology

Product Theaters

Treatment Considerations, Biological therapies

Room 3 (San Diego Convention Center)

Speaker:

David Hughes, PharmD, BCOP, Pfizer Inc

Disclosures:

No relevant conflicts of interest to declare.

For in-person participants only

See more of: Product Theaters